Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Scinai Immunotherapeutics Ltd
SCNI
Healthcare
Biotechnology
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various...
diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SCNI)
New Post
View:
Posts & Comments
Threaded Posts
(271)
•••
whytestocks
X
Post by
whytestocks
on Nov 27, 2024 12:00pm
Dr. Jonathan Sadeh, Former Senior Vice President of Immunolo
BREAKING NEWS: $SCNI Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory BoardDr. Jonathan Sadeh
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Sep 16, 2024 7:17pm
InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ:
BREAKING NEWS: $SCNI InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Schedules Virtual Panel Discussion on Plaque Psoriasis, Its Promising Novel SolutionScinai Immunotherapeutics
...more
Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents
posted Dec 03, 2024 9:00am by
Revive Therapeutics Ltd
-
|
Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more
(271)
•••
whytestocks
X
Post by
whytestocks
on Aug 21, 2024 8:00pm
InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NA
BREAKING NEWS: $SCNI InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), EIB Close on Loan Restructuring AgreementScinai Immunotherapeutics (NASDAQ: SCNI) , a
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Aug 20, 2024 11:02am
Scinai Announces Entering into $2 Million Private Equity Com
News; $SCNI Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing ShareholderScinai Announces Entering into $2 Million Private Equity Commitment
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Aug 15, 2024 9:02pm
InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ:
BREAKING NEWS: $SCNI InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Results, Shares Business UpdateScinai Immunotherapeutics (NASDAQ: SCNI) is a
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 17, 2024 9:30am
SCNI....DEBT to Equity conversion..... Sheesh
You will all get screwed.....go ahead and be a CHaser !!!! Now at $6.20.....watch out !!!!!!!!!!!!!!!!!!!!!!!!
(271)
•••
whytestocks
X
Post by
whytestocks
on Jun 07, 2024 5:30pm
NIH Researchers Unveil AI Tool to Predict Oncology Patients'
NEWS: $SCNI NIH Researchers Unveil AI Tool to Predict Oncology Patients' Response to ImmunotherapyScientists at the National Institutes of Health have designed an artificial intelligence (AI) tool
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 05, 2023 3:45pm
BVXV....Now if I was a gambling man....
I'd buy this L.O.D.....because theres a gap just over $1.69 that should get filled before the close which is in 15 minutes Me ...no position !
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 05, 2023 3:21pm
BVXV.... Done for the year ?
LMFAO !!!!
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 05, 2023 3:05pm
BVXV..... Is that a "Green to Red" move..... LoL
Never ceases to amaze me !!!
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 05, 2023 11:38am
BVXV....Phew.....call me lucky ; )
Dodged a bullet there But I've re-loaded.....fingers crossed What a game
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 05, 2023 11:33am
BVXV.....sold into that pop
I just take what the market gives I like leaving some for the next guy.....seriously.....this could easily pop Remember my target ; )
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 05, 2023 11:23am
BVXV.....whoa....this might not be done.....this needs some
volume Right at a crucial pivot that I previously mentioned $3.50 target .... Cheers !
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 05, 2023 11:00am
BVXV....this is finished
Cheers !
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 05, 2023 10:49am
BVXV....this needs to break $2.06
Plus vol increase
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
Featured News Links
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing